In addition, less than 30% of patients remain on treatment for more than a year 6,7,8 , and treatment discontinuation typically results in rapid weight regain 4,9,10 , with the majority of this gain attributed to increases in fat mass 11,12,13
But researchers who are also taking insulin, sulfonylureas, or other glucose-lowering agents face meaningful hypoglycemia risk
Contrast this with the peptides which faced major supply issues between 2023-2025 that compromised diabetic patient safety and led to higher prices, unequal access and a rise in fake medicines
Muchas personas me preguntan si realmente funciona para bajar de peso , cules son sus beneficios, limitaciones y si podra ser una alternativa a la ciruga baritrica
Antipova T, Sapozhnikova D, Liu B, Seredenin S